Body size and prostate cancer: A 20-year follow-up study among 135 006 Swedish construction workers

Journal of the National Cancer Institute

Volumn 89, Issue 5, 1997, Pages 385-389

  Andersson, Swen Olof ^a,b   Wolk, Alicja ^c   Bergström, Reinhold ^c,d   Adami, Hans Olov ^b,e,f   Engholm, Göran ^g   Englund, Anders ^h   Nyrén, Olof ^c  

^a ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c University Hospital   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

^e University Hospital   (United States)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^g NATIONAL BOARD OF HEALTH AND WELFARE   (Sweden)

^h Natl Bd of Occup Safety and Hlth   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY HEIGHT; BODY MASS; BODY SIZE; BODY WEIGHT; CANCER INCIDENCE; CANCER MORTALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; SWEDEN; WORKER;

EID: 0031052119     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.5.385     Document Type: Article

References (47)

1. Nomura AM, Kolonel LN. Prostate cancer: a current perspective. Epidemiol Rev 1991;13: 200-27.
2. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J, editors. Cancer incidence in five continents, vol VI. IARC Sci Publ. No. 120. Lyon: International Agency for Research on Cancer, 1992.
3. Haenszel W, Kurihara M. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 1968;40:43-68.
4. Pienta KJ, Esper PS. Is dietary fat a risk factor for prostate cancer? [editorial]. J Natl Cancer Inst 1993;85:1538-40.
5. Ohno Y, Yoshida O, Oishi K, Okatia K, Yamabe H, Schroeder FH. Dietary beta-carotene and cancer of the prostate: a case-control study in Kyoto, Japan. Cancer Res 1988;48:1331-6.
6. Rohan TE, Howe GR, Burch JD, Jain M. Dietary factors and risk of prostate cancer: a case-control study in Ontario, Canada. Cancer Causes Control 1995;6:145-54.
7. Andersson SO, Wolk A, Bergstrom R, Giovannucci E, Lindgren C, Baron J, et al. Energy, nutrient intake and prostate cancer risk: a population-based case-control study in Sweden. Int J Cancer 1996;68:716-22.
8. Hirayama T. Epidemiology of prostate cancer with special reference to the role of diet. Natl Cancer Inst Monogr 1979;53:149-55.
9. Severson RK, Nomura AM, Stemmermann GN. A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 1989;49: 1857-60.
10. Hsing AW, McLaughlin JK, Schuman LM, Bjelke E, Gridley G, Wacholder S, et al. Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study. Cancer Res 1990;50:6836-40.
11. Zumoft B. Hormonal abnormalities in obesity. Acta Med Scand Suppl 1988;723:152-60.
12. Ross RK, Henderson BE. Do diet and androgens alter prostate cancer risk via a common etiologic pathway? [editorial]. J Natl Cancer Inst 1994;86:252-4.
13. Nyren O, Bergstrom R, Nystrom L, Engholm G, Ekbom A, Adami HO, et al. Smoking and colorectal cancer: a 20-year follow-up study of Swedish construction workers. J Natl Cancer Inst 1996;88:1302-7.
14. Mattson B. The completeness of registration in the Swedish Cancer Registry. Stockholm: Stat Rep HS; Report No. 15, 1977.
15. McCullagh P, Neider JA. Generalised linear models. 2nd edition. London: Chapman & Hall, 1989.
16. Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropométrie measurements. Am J Clin Nutr 1980;33:27-39.
17. Sheng HP, Huggins RA. A review of body composition studies with emphasis on total body water and fat. Am J Clin Nutr 1979;32: 630-47.
18. The Cancer Registry. Cancer incidence in Sweden 1992. Stockholm: National Board of Health and Welfare, 1995.
19. Kolonel LN. Nutrition and prostate cancer. Cancer Causes Control 1996;7:83-94.
20. Wynder EL, Mabuchi K, Whitmore WF Jr. Epidemiology of cancer of the prostate. Cancer 1971;28:344-60.
21. Graham S, Haughey B, Marshall J, Priore R, Byers T, Rzepka T, et al. Diet in the epidemiology of carcinoma of the prostate gland. J Natl Cancer Inst 1983;70:687-92.
22. Ross RK, Shimizu H, Paganini-Hill A, Honda G, Henderson BE. Case-control studies of prostate cancer in blacks and whites in southern California. J Natl Cancer Inst 1987;78:869-74.
23. Kolonel LN, Yoshizawa CN, Hankin JH. Diet and prostatic cancer: a case-control study in Hawaii. Am J Epidemiol 1988;127:999-1012.
24. Mettlin C, Selenskas S, Natarajan N, Huben R. Beta-carotene and animal fats and their relationship to prostate cancer risk. A case-control study. Cancer 1989;64:605-12.
25. La Vecchia C, Negri E, Parazzini F, Boyle P, D'Avanzo B, Levi F, et al. Height and cancer risk in a network of case-control studies from northern Italy. Im J Cancer 1990;45:275-9.
26. West DW, Slattery ML, Robison LM, French TK, Mahoney AW. Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors. Cancer Causes Control 1991;2:85-94.
27. Whittemore AS, Kolonel LN, Wu AH, John EM, Gallagher RP, Howe GR, et al. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst 1995;87:652-61.
28. Snowdon DA, Phillips RL, Choi W. Diet, obesity, and risk of fatal prostate cancer. Am J Epidemiol 1984;120:244-50.
29. Severson RK, Grove JS, Nomura AM, Stemmermann GN. Body mass and prostatic cancer: a prospective study. BMJ 1988;297:713-5.
30. Garfinkel L. Overweight and mortality. Cancer 1986;58:1826-9.
31. Thompson MM, Garland C, Barrett-Connor E, Khaw KT, Friedlander NJ, Wingard DL. Heart disease risk factors, diabetes, and prostatic cancer in an adult community. Am J Epidemiol 1989;129:511-7.
32. Talamini R, La Vecchia C, Decarli A, Negri E, Franceschi S. Nutrition, social factors and prostatic cancer in a Northern Italian population. Br J Cancer 1986;53:817-21.
33. Fincham SM, Hill GB, Hanson J, Wijayashinghe C. Epidemiology of prostate cancer: a case-control study. Prostate 1990;17:189-206.
34. Simopoulos AP. Energy imbalance and cancer of the breast, colon and prostate. Med Oncol Tumor Pharmacother 1990;7:109-20.
35. Lee IM, Paffenbarger RS Jr, Hsieh CC. Physical activity and risk of prostatic cancer among college alumni. Am J Epidemiol 1992;135: 169-79.
36. Troisi RJ, Weiss ST, Parker DR, Sparrow D, Young JB, Landsberg L. Relation of obesity and diet to sympathetic nervous system activity. Hypertension 1991;17:669-77.
37. Wang JM, McKenna KE, McVary KT, Lee C. Requirement of innervation for maintenance of structural and functional integrity in the rat prostate. Biol Reprod 1991;44:1171-6.
38. Furukawa S, Furukawa Y. Nerve growth factor synthesis and its regulatory mechanisms: an approach to therapeutic induction of nerve growth factor synthesis. Cerebrovasc Brain Metab Rev 1990;2:328-44.
39. Isley WL, Underwood LE, Clemmons DR. Dietary components that regulate serum somatomedin-C concentrations in humans. J Clin Invest 1983;71:175-82.
40. Clemmons DR, Underwood LE, Dickerson RN, Brown RO, Hak LJ, MacPhee RD, et al. Use of plasma somatomedin-C/insulin-like growth factor I measurements to monitor the response to nutritional repletion in malnourished patients. Am J Clin Nutr 1985;41: 191-8.
41. Unterman TG, Vazquez RM, Slas AJ, Martyn PA, Phillips LS. Nutrition and somatomedin. XIII. Usefulness of somatomedin-C in nutritional assessment. Am J Med 1985;78:228-32.
42. Gann PH, Daviglus ML, Dyer AR, Stamler J. Heart rate and prostate cancer mortality: results of a prospective analysis. Cancer Epidemiol Biomarkers Prev 1995;4:611-6.
43. Mortensen PB. Neuroleptic medication and reduced risk of prostate cancer in schizophrenic patients. Acta Psychiatr Scand 1992;85: 390-3.
44. Le Marchand L, Kolonel LN, Wilkens LR, Myers BC, Hirohata T. Animal fat consumption and prostate cancer: a prospective study in Hawaii. Epidemiology 1994;5:276-82.
45. Daughaday WH, Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 1989;10:68-91.
46. Keenan BS, Richards GE, Ponder SW, Dallas JS, Nagamani M, Smith ER. Androgen-stimulated pubertal growth: the effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-1 in the treatment of short stature and delayed puberty. J Clin Endocrinol Metab 1993;76:996-1001.
47. Juul A, Dalgaard P, Blum WF, Bang P, Hall K, Michaelsen KF, et al. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-1, IGF-II, IGFBP-2, IGFBP-2; age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 1995;80:2534-42.